Aurora Cannabis and Radient Technologies Announce First Commercial…

Visit the Aurora Cannabis Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

Transformational Milestone for Radient, Increasing Aurora’s Global Derivative Market Capacity Substantially

EDMONTON, May 13, 2019 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE:ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) and Radient Technologies Inc. (“Radient”) (TSX Venture: RTI;OTCQX: RDDTF), announced today that Aurora has taken delivery of Radient’s first commercial batch of finished cannabis derivatives, from Radient’s proprietary extraction platform. With this first batch, Radient has proven its enhanced ability to produce cannabinoid derivatives at commercial scale, and will continue to scale up production at Radient’s cannabis facility in Edmonton, reaching an expected eventual annual throughput of approximately 300,000 kg of cannabis biomass at this

... read more at: https://www.newcannabisventures.com/aurora-cannabis-and-radient-technologies-announce-first-commercial-delivery-of-cannabis-derivatives/